Novartis On Payer Contracts, Other Updates From BIO CEO & Investor Conference
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis' recent arrangements with Cigna and Aetna tying Entresto reimbursement to outcomes, new Gilead hires and a potential labeling change for Relypsa's Veltassa.